Results 271 to 280 of about 192,948 (305)
Some of the next articles are maybe not open access.

The Impact of Paricalcitol on Left Ventricular Hypertrophy

2011
Cardiovascular (CV) morbidity and mortality are significantly higher in patients with chronic kidney disease (CKD). Mineral metabolism disorders, such as hyperphosphatemia, hypocalcemia, and vitamin D deficiency, have been deeply associated not only with bone disease, but also with vascular calcification and CV disease.
Cozzolino M, Ronco C
openaire   +5 more sources

Left Ventricular Hypertrophy in Hypertension [PDF]

open access: possibleHeart Drug, 2002
Because of the importance of left ventricular (LV) hypertrophy (LVH) as a strong independent risk factor for adverse cardiovascular events, clinical trials of the treatment of hypertension have recently focused on the efficacy of antihypertensive agents to decrease LV mass.
openaire   +1 more source

Left Ventricular Hypertrophy

2004
Left ventricular hypertrophy (LVH) is a common pathologic finding, occurring in about 20% of a population of 50-year-olds, and more in older people. It represents an independent predictor of premature death that is as important as frequent ventricular premature beats.
openaire   +2 more sources

Hypertension and left ventricular hypertrophy

Journal of Hypertension
In the initial stage, left ventricular hypertrophy (LVH) is adaptive, but in time, it transforms to maladaptive LVH which is specific for the development of various phenotypes that cause heart failure, initially with preserved, but later with reduced left ventricular ejection fraction.
Dragan B, Đorđević   +3 more
openaire   +2 more sources

Microcirculation and left-ventricular hypertrophy

Journal of Hypertension, 2012
F. Angeli   +2 more
openaire   +3 more sources

A Man With Left Ventricular Hypertrophy

JAMA Cardiology, 2022
Nana, Hiraki   +2 more
openaire   +2 more sources

Left-ventricular hypertrophy in obesity

Journal of Hypertension, 2014
Messerli, Franz H., Ventura, Hector
openaire   +4 more sources

Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management

Ca-A Cancer Journal for Clinicians, 2016
Giuseppe Curigliano   +2 more
exaly  

Left ventricular hypertrophy in hypertension

Journal of Molecular and Cellular Cardiology, 1989
Y. Yazaki, Edward D. Frohlich
openaire   +3 more sources

Home - About - Disclaimer - Privacy